Drug target alteration refers to changes in the molecular targets of cancer drugs that can lead to resistance or reduced efficacy of treatments. These targets are typically proteins or genes that the drug is designed to interact with to inhibit cancer cell growth or survival. Alterations can occur due to genetic mutations, modifications in protein expression, or other cellular changes.
